High Grade Gliomas Completed Phase 2 Trials for Temozolomide (DB00853)

IndicationStatusPhase
DBCOND0034320 (High Grade Gliomas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00302159Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain TumorsTreatment